Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_assertion type Assertion NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_head.
- NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_assertion description "[Patients with Down's syndrome (trisomy 21) have an increased expression of MxA protein, and their cells display an increased sensitivity to IFNs in vitro because of gene dosage effects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_provenance.
- NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_assertion evidence source_evidence_literature NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_provenance.
- NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_assertion SIO_000772 7551417 NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_provenance.
- NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_assertion wasDerivedFrom befree-20150227 NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_provenance.
- NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_assertion wasGeneratedBy ECO_0000203 NP580365.RA80oMo0wkfth5TEF5PdNC6bsebmac5yFFGWL6LMyt_cQ130_provenance.